Breaking News
Sort by:
Top Post
Novalis Biotech Invests in Ultra Sensitive Genomics Technology by Rarity Bioscience
Rarity Bioscience announces a new strategic investment from Belgium-based Novalis Biotech. The investment is facilitated […]
Day Zero Diagnostics Announces Completion of $21M Financing
Day Zero Diagnostics, Inc., an infectious disease diagnostics company harnessing the power of whole-genome sequencing […]
PrecisionLife Announces First Close of Series A Financing to Progress its Drug Discovery Pipeline and Commercial Partnerships
PrecisionLife Limited, a global techbio company driving precision medicine in chronic disease with AI-led drug […]
CONDOR Project for Precision Medicine and Sarcoma Immunotherapy Awarded Close to €10M in the Fifth Call for Hospital-University Research in Health (RHU) Projects
The CONDOR consortium, led by Pr. Antoine Italiano of the Bergonié Institute (Bordeaux, France) is […]
Leaps by Bayer Leads $80M Series A Financing for Cellino Biotech to Autonomize Stem Cell Therapy Manufacturing
Cellino Biotech, Inc., an autonomous cell therapy manufacturing company, today announced the completion of a […]
SBRI Healthcare Awards £1 Million to Pioneering Innovations to Support the Delivery of a Net Zero NHS
SBRI Healthcare has awarded a total of £1 million to ten pioneering MedTech and Digital […]
Spartha Medical Receives €2.4M in Financing from European Innovation Council
Spartha Medical, a French medtech company specialized in developing multifunctional antimicrobial, antiviral and anti-inflammatory coatings, […]
Cytovation Raises $20 Million in Series A Financing Round to Advance Clinical Development of CyPep-1, a First-in-Class Targeted Tumor Membrane Immunotherapy
Cytovation AS, a clinical stage immune-oncology company focused on the development of its first-in-class targeted […]
NuvoAir Series A Funding Reaches $25M to Expand Patient-Centric Care and Clinical Trials Platform
NuvoAir, a leading digital healthcare company working in chronic disease management, raised $11M in a […]
Amniotics Secures Funding of SEK 4,8 Million from Vinnova to Develop Stem Cell Therapies
Amniotics AB (publ) (Nasdaq Stockholm: AMNI) today announced that it has received a non-diluting grant […]
Wandercraft Closes $45 Million Series C Financing to Accelerate Delivery of the World’s First Personal Self-Balanced Exoskeleton
Wandercraft, a leading healthtech company in dynamic robotics and exoskeleton technology, announced today a $45 million equity […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more